BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24083693)

  • 1. Hepatitis B virus gene mutations and hepatocarcinogenesis.
    Liang T; Chen EQ; Tang H
    Asian Pac J Cancer Prev; 2013; 14(8):4509-13. PubMed ID: 24083693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
    Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
    World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The characteristic changes in hepatitis B virus x region for hepatocellular carcinoma: a comprehensive analysis based on global data.
    Li W; Goto K; Matsubara Y; Ito S; Muroyama R; Li Q; Kato N
    PLoS One; 2015; 10(5):e0125555. PubMed ID: 25942596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma and hepatitis B virus.
    Chan HL; Sung JJ
    Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
    Muroyama R; Kato N; Yoshida H; Otsuka M; Moriyama M; Wang Y; Shao RX; Dharel N; Tanaka Y; Ohta M; Tateishi R; Shiina S; Tatsukawa M; Fukai K; Imazeki F; Yokosuka O; Shiratori Y; Omata M
    J Hepatol; 2006 Dec; 45(6):805-12. PubMed ID: 17050029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma.
    Lin YT; Jeng LB; Chan WL; Su IJ; Teng CF
    Viruses; 2021 May; 13(5):. PubMed ID: 34066744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.
    Shinkai N; Tanaka Y; Ito K; Mukaide M; Hasegawa I; Asahina Y; Izumi N; Yatsuhashi H; Orito E; Joh T; Mizokami M
    J Clin Microbiol; 2007 Oct; 45(10):3191-7. PubMed ID: 17652471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis].
    Koike K
    Nihon Rinsho; 1999 Jan; 57(1):213-9. PubMed ID: 10036965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transgenic mouse model for hepatocellular carcinoma in human hepatitis B virus infection].
    Koike K
    Nihon Rinsho; 1993 Feb; 51(2):536-41. PubMed ID: 8385245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basic research for HBV-related hepatocarcinogenesis].
    Oishi N; Kaneko S
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():382-5. PubMed ID: 26845963
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of HBV-induced hepatocellular carcinoma.
    Levrero M; Zucman-Rossi J
    J Hepatol; 2016 Apr; 64(1 Suppl):S84-S101. PubMed ID: 27084040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta-regression analysis.
    Zhou HY; Luo Y; Chen WD; Gong GZ
    J Gastroenterol Hepatol; 2015 Jun; 30(6):977-83. PubMed ID: 25689418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinoma.
    Song C; Liu Y; Xu L; Wen J; Jiang D; Chen J; Zhai X; Hu Z; Liu L; Liu J
    Cancer Med; 2016 Jul; 5(7):1687-93. PubMed ID: 27075395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
    Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
    Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Biological Function of Hepatitis B Virus X Protein in Hepatocellular Carcinoma.
    Xu Q; Gu S; Liang J; Lin Z; Zheng S; Yan J
    Oncol Res; 2019 Mar; 27(4):509-514. PubMed ID: 29891022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus in hepatocarcinogenesis.
    Feitelson MA
    J Cell Physiol; 1999 Nov; 181(2):188-202. PubMed ID: 10497299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.